You are here

Global Healthcare CMO Market to 2023 - Focus on Pharmaceutical CMOs, Active Pharmaceutical Ingredients (API), Finished Dosage Formulations (FDF)

DUBLIN, July 30, 2019 /PRNewswire/ -- The "Global Healthcare CMO Market (2019-2023 Edition)" report has been added to ResearchAndMarkets.com's offering.

Global Healthcare CMO Market (2019-2023 Edition) provides a detailed analysis global healthcare CMO market with market sizing and growth. The analysis includes market size in terms of value, and market share by segments. A comprehensive segment analysis has also been provided in the report with their historical and forecasted value.

An outsourcing in which a pharmaceutical firm contacts with a third party (contract manufacturing organization) for the manufacturing of components of its product or whole of its product is known as contract manufacturing. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm.

A firm either big or mid-size selects a CMO for primarily two reasons: it wants to shift (or cut) its cost and focus to its core activities, or the development of its products require special or expert handling.

CMOs provide independent manufacturing services in healthcare sector also. Healthcare CMOs can be segmented into pharmaceutical CMOs and medical device CMOs. After the discovery of chemical formula of a new drug, the pharmaceutical CMOs are given the task of manufacturing it into a whole product, so that the pharmaceutical companies are able to sell it into the market under their brand name.

Services offered by pharmaceutical CMOs can be divided into two main activities: primary manufacturing (Active Pharmaceutical Ingredients) and secondary manufacturing (Finished Dosage Formulation). Contract manufacturing for medical devices is one of the fastest growing segments of the medical device industry, as companies are in the race to bring new devices to the market.

The global healthcare CMO market has recorded continuous growth over the past few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMO industry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceutical companies.

This report also provides the analysis of global pharmaceutical CDMO market. This analysis includes the global pharmaceutical CDMO market by value, and by geography. The regional analysis of global pharmaceutical CDMO market is also done in this report. The regions included are United States of America, Europe, China and India.

Company profiling of major players of healthcare CMO industry such as Catalent Pharma Solution, Recipharm, Aurobindo Pharma Ltd. and Boehringher Ingelheim has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.

Key Topics Covered:

1. Executive Summary

2. Introduction
2.1 Contract Manufacturing: An Overview
2.1.1 Healthcare CMOs
2.1.2 Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs, Active Pharmaceutical Ingredients (API), Finished Dosage Formulations (FDF)
2.1.4 Medical CMOs
2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments
2.3 Pharmaceutical CMOs v/s CDMOs

3. Global Market Analysis
3.1 Global Healthcare CMO Market Analysis
3.1.1 Global Healthcare CMO Market by Value
3.1.2 Global Healthcare CMO Market by Segments
3.2 Global Healthcare CMO Market: Segment Analysis
3.2.1 Global Medical Device CMO Market by Value
3.2.2 Global Pharmaceutical CMO Market by Value
3.3 Global Pharmaceutical CMO Market Analysis
3.3.1 Global Pharmaceutical CMO Market by Segments
3.3.2 Global Pharmaceutical CMO Market by Region
3.4 Global Pharmaceutical CMO Market: Segment Analysis
3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value
3.4.2 Global Finished Dosage Formulation CMO Market by Value
3.4.3 Global Other Pharmaceutical Services CMO Market by Value
3.5 Global Pharmaceutical CDMO Market Analysis
3.5.1 Global Pharmaceutical CDMO Market by Value
3.5.2 Global Pharmaceutical CDMO Market by Region

4. Regional Analysis
4.1 The U.S. Pharmaceutical CDMO Market Analysis
4.1.1 The U.S. Pharmaceutical CDMO Market by Value
4.2 Europe Pharmaceutical CDMO Market Analysis
4.2.1 Europe Pharmaceutical CDMO Market by Value
4.3 India Pharmaceutical CDMO Market Analysis
4.3.1 India Pharmaceutical CDMO Market by Value
4.4 China Pharmaceutical CDMO Market Analysis
4.4.1 China Pharmaceutical CDMO Market by Value

5. Competitive Landscape
5.1 Global Healthcare CMO Market Players Financial Comparison

6. Company Profiles

  • Aurobindo Pharma Ltd.
  • Boehringher Ingelheim
  • Catalent Pharma Solution
  • Recipharm

For more information about this report visit https://www.researchandmarkets.com/r/g4ebsf

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-healthcare-cmo-market-to-2023---focus-on-pharmaceutical-cmos-active-pharmaceutical-ingredients-api-finished-dosage-formulations-fdf-300893257.html

SOURCE Research and Markets